clinical trial · NCT05796037
An Observational Study of Patients Living With Chronic Neurological Diseases
Target PharmaSolutions, Inc.·—·not yet recruiting·n = 1,500,000
Neurological Diseases or ConditionsDementia of Alzheimer TypeAlzheimer DiseaseMild Cognitive ImpairmentParkinson DiseaseMultiple Sclerosis
brief summary
TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).
started
Mar 31, 2025
primary completion
Dec 31, 2038
completion
Dec 31, 2038
last updated
Nov 20, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol